Mannitol Viaflo Baxter

Mannitol, the active ingredient in Mannitol Viaflo Baxter, is an osmotic diuretic presented as a sterile injectable solution for intravenous use. It is employed to lower elevated intracranial pressure, to promote diuresis in acute renal failure, and to aid the renal elimination of certain toxins in hospitalized patients.

GNH USA supplies Mannitol Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol is used in renal and neurocritical care to manage fluid balance and pressure abnormalities.

- Reduction of intracranial pressure: lowers cerebral edema and intracranial hypertension. - Acute renal failure: increases urine output to support renal clearance. - Renal excretion of toxins: enhances elimination of nephrotoxic substances and certain drugs.

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea or vomiting: transient gastrointestinal upset. - Electrolyte disturbances: especially hyponatremia or hyperkalemia. - Transient hypotension: due to rapid plasma volume expansion.

Serious or Rare Side Effects: - Acute renal failure: worsening kidney function in susceptible patients. - Pulmonary edema: fluid overload in patients with compromised cardiac function. - Severe electrolyte imbalance: leading to cardiac arrhythmias. - Hemolysis: particularly in patients with G6PD deficiency. - Anaphylactoid reactions: rare hypersensitivity with rash or bronchospasm.

Mannitol should be administered with careful monitoring of fluid status and laboratory parameters.

- Renal function: assess baseline creatinine and urine output before use. - Cardiac status: avoid rapid infusion in patients with heart failure. - Electrolytes: monitor serum sodium, potassium, and osmolality regularly. - Volume status: adjust infusion rate to prevent fluid overload. - Storage: Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Mannitol can alter the pharmacokinetics of several co‑administered agents.

Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte loss and renal impairment. - Nephrotoxic antibiotics (e.g., aminoglycosides): increased risk of renal toxicity.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible additive hypotensive effect. - Insulin or oral hypoglycemics: osmotic shifts may affect glucose control. - Lithium: altered renal clearance may raise serum lithium levels.